Mr. Barry Balfe
CEO, ICON Pharma Development Solutions
Title: From Development Strategy to Global Clinical Execution: Building Effective Pharma Partnerships
Invitation-only • Curated admission • Limited seats
|
Dates: 20–22 January 2027
|
Venue: Singapore
Featured Leaders • Executive + Academia + Industry
ECTMBICS 2027 Featured Leaders
Meet senior leaders and invited speakers contributing to strategic dialogue across translational medicine, biotech innovation, pharma development, clinical research, genomics, digital health, and clinical commercialisation.
Leader engagement
Curated leader sessions are designed for clinical insight, biotech strategy, institutional exchange, and healthcare innovation outcomes.
Congress dates
20–22 January 2027
Location
Singapore
Participation model
Apply → Review → Confirm
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
High-trust leader sessions
Roundtables • clinical dialogue • biotech partnerships • healthcare innovation
Home
/
Featured Leaders
View Agenda →
Note: Session order and final programme timings will be updated closer to the congress dates.
Featured Leaders
Senior clinical, translational, and industry leaders shaping evidence generation, implementation pathways, biotech strategy, and patient impact.
Prof. Han-Chung Wu
Biomedical Translation Research Center (BioTReC), Taiwan
Title: Advancing Biomedical Translation from Discovery Platforms to Clinical Applications
Matthew Hewitt
Charles River Laboratories
Title: Preclinical Models and Translational Pathways for Next-Generation Therapeutics
Prof. Lani Wu
University of California, San Francisco
Title: Systems-Level Approaches to Translational Medicine and Biomedical Discovery
Dr. Feng-Chi Chen
Institute of Population Health Sciences, National Health Research Institutes
Title: Population Health Evidence and Implementation Pathways for Clinical Translation
Marc Goemans
Chief Commercial Officer, Bora Biologics
Title: Biologics Manufacturing, Commercial Strategy and Global Partnership Models
Dr. Guillermo Del Angel
Center for Genomics Research, AstraZeneca
Title: Genomics-Driven Precision Medicine: Translating Data into Therapeutic Insight
Ed Deng
Co-Founder and CEO, Health2Sync
Title: Digital Health Platforms for Patient Engagement, Monitoring and Clinical Outcomes
Sanghoon Park
CEO, Illimis Therapeutics, Korea
Title: Therapeutics Innovation and Biotech Leadership in Emerging Clinical Pipelines
Important
ECTMBICS 2027 is executive-only. Participation is curated to protect relevance, confidentiality, and outcomes across the congress environment.